250 Views
Panel Session
Renato Porto, Director
Director
National Sanitary Surveillance Agency – ANVISA
Gabrielle Troncosco
Head of Good Regulatory Pratices
Anvisa
In this session, ANVISA will review its recent regulatory impact assessment regarding monitoring of medical device prices and the next steps related to public consultation and methodologies.